As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Experts: Notified body survey shows MDR/IVDR progress despite some snags

A recent survey shows progress in the number of applications being filed with notified bodies (NB) and certificates issued under the EU Medical Device...

Europe – Q&A Obligation to inform in case of interruption or discontinuation of supply

Introduction – Objectives of the MDR/IVDR amendment The amendment of the MDR and of the IVDR through Regulation (EU) 2024/1860 addresses three topics: 1. Regulation (EU)...

USA – Data Normalization Challenges and Mitigations in Software Bill of Materials (SBOM) Processing:...

The Mitre Corporation says stakeholders should work together to normalize how software bill of materials (SBOMs) are implemented in a newly published white paper,...

Europe – Notified body official shares recommendations for successful PMCF plans

Successful postmarket clinical follow-up plans (PMCFs) should be able to provide new information that was not previously known about a device, such as delayed...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2022 – 5 Rev. 1 Guidance on borderline between medical devices...

The demarcation between the Regulation (EU) 2017/745 on medical devices (MDR) on the one hand and the Directive 2001/83/EC on the Community code relating to...

Europe – MDCG 2024-13 Regulatory status of ethylene oxide (EtO) intended for the...

The regulatory status of ethylene oxide (EtO) for the sterilisation of single-use medical devices during the manufacturing process has been discussed in relation to...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What...

On 21 October 2024, the UK Government laid the draft Post-market Surveillance statutory instrument (“PMS SI”) before Parliament (see the UK Medicines and Healthcare products Regulatory Agency’s...

Europe – EMA official reports on scientific advice pilots for high-risk and orphan devices

A European Medicines Agency (EMA) official provided an update on the agency’s pilot programs aimed delivering scientific advice to manufacturers of high-risk and orphan...
TEAM-NB : Survey on NBs applications against IVD new regulation

Europe – Team-NB views on implementation of MDR/IVDR Regulations

At the Team-NB general assembly meeting, held on October 9th, the members aligned on a strategy including operational aspects to respond to the concerns regarding...
TÜV Rheinland Becomes 5th Notified Body Designated Under MDR

Europe – Urgent need to revise the medical devices regulation

The European Parliament, – having regard to the Treaty on the Functioning of the European Union, and in particular Article 168 thereof, – having regard to Regulation...

NOS PROCHAINES FORMATIONS